A new hope for aggressive thoracic cancers: foundational efficacy of frontline immunotherapy in SMARCA4-deficient tumors.

Transl Lung Cancer Res · 2025 · PMC12683402 · PMID 41367571

Europe PMC DOI

hedged sentence

0.2700

closest p · 5.4× alpha

0.2700

boldest claim

The sentences

did not reach statistical significanceP=0.27not close (p > 0.1)

6.95 months), though this difference did not reach statistical significance (P=0.27) ( 1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.